FINWIRES · TerminalLIVE
FINWIRES

Germany's Manufacturing Production Contracts in February on Lower Pharmaceuticals, Electronics Output

-- Production in Germany's manufacturing sector unexpectedly declined month over month in February, even before the war in the Middle East began, as output from the pharmaceuticals and electronics industries weakened, provisional data from the Federal Statistical Office showed Thursday.

Real, price-adjusted manufacturing output dropped 0.3% in February, after seasonal and calendar changes, compared with the upwardly revised stagnation in January. The consensus estimate for February was a 0.9% rise.

On a monthly basis, production of pharmaceuticals and computer, electronic, and optical products contracted 4.4% and 3.9%, respectively. Amid the cold winter weather, construction output slipped 1.2%, while automotive production improved 1.7%. Destatis data paints a picture of a "very reluctant, hesitant consumer," while the manufacturing sector struggles to gain positive momentum, said Carsten Brzeski, the global head of macro at ING.

Annually, German manufacturing output after calendar adjustment was stable, against the revised 0.9% decrease in January. Excluding energy and construction, industrial production in February slipped 0.1% on the month and 0.6% on the year.

In energy-intensive industries, which account for 17% of industrial gross value, production expanded 1.9% month over month and 0.1% on a yearly basis. Consumer goods production fell 1.5% sequentially, while the output of intermediate goods and capital goods rose by 0.4% and 0.1%, respectively. Germany, one of Europe's largest net importers of energy, clocked a 0.3% monthly gain in energy production in February.

"All in all, February's macro data shows that even without the war in the Middle East, the German economy was unfortunately on track for yet another quarter of contraction. To make things worse, the war in the Middle East, no matter how sustainable yesterday's announced ceasefire will prove to be, will leave clear marks on the German economy over the next few months. As much as we were hoping to finally comment on some good economic news from Germany, it is a bit like waiting for a German train these days: definitely delayed and uncertain whether it will ever arrive," Brzeski concluded.

Related Articles

Research

Research Alert: Rs Posts Q1 Sales And Eps Beat, Record Volumes And Major Contract Wins

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:RS reported Q1 2026 adj. EPS of $5.16 vs. $4.66 consensus, exceeding guidance, with net sales of $4.03B beating consensus by $118M on record tons sold of 1.67M (+9.4% Q/Q, +2.7% Y/Y). Gross margin recovered to 29.1% (+180 bps Q/Q), moving within the company's 29%-31% target range as LIFO headwinds moderated. RS outperformed industry shipments by ~8%-pts, marking the 13th consecutive of outpacing industry growth, with broad-based performance across carbon steel, aluminum, and stainless steel categories. Management guided for Q2 2026 adj. EPS of $5.15-$5.35, reflecting confidence in sustained pricing momentum across key end markets. RS secured $2.9B in government contracts, including a $2.24B border wall contract and a $654M Joint Strike Fighter renewal. We believe the aluminum recovery is particularly meaningful given 2025's tariff-related compression, and disciplined capital allocation with $301M returned to shareholders demonstrates balance sheet strength at 1.0x net debt-to-EBITDA.

$RS
Research

Research Alert: CFRA Lowers Opinion On Shares Of Expedia Group Inc. From Hold To Sell

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $3 to $240, representing 13x our 2026 EPS estimate (unchanged multiple), a significant discount to EXPE's 21x five-year average forward multiple. We lower our 2026 EPS estimate to $18.51 from $18.55 and 2027's to $20.38 from $20.42, reflecting modestly lower gross bookings growth expectations. We downgrade EXPE from Hold to Sell as we believe shares are overvalued given heightened macroeconomic risks and the company's concentrated U.S. exposure. Elevated oil prices are pressuring U.S. consumer discretionary budgets, which would disproportionately impact EXPE relative to peers given approximately 60% of its business is U.S.-based. Consensus revenue estimates have been revised up 6% on recent bookings momentum but have been slow to reflect recent macroeconomic volatility, suggesting potential downside risk. Additionally, AI-driven search and booking tools represent a longer-term disintermediation threat to EXPE's traditional online travel agency model.

$EXPE
Asia

Huaqin Nets HK$4.5 Billion From Hong Kong IPO Ahead of Debut

Huaqin (HKG:3296, SHA:603296) raised HK$4.46 billion in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$77.70 per H-share, according to a Wednesday after-market filing with the Hong Kong Stock Exchange.The China-based smart hardware products manufacturer offered 58.5 million H-shares in the global offering.The Hong Kong public offer was 531.33 times subscribed, with a final allocation of 5.9 million shares, representing 10% of the total offering.The international offering was 13.34 times subscribed, with a final allocation of 52.7 million shares, or 90% of the total offering.An over-allocation of 8.8 million shares was made under the global offering.Cornerstone investors, including JPMAMAPL, UBS Asset Management (Singapore), Shanghai Gaoyi, Perseverance Asset Management, Cloud Map, Taikang Life, and Aurora SF, were allotted a combined 29.3 million shares, according to the filing.Huaqin is scheduled to debut on the Hong Kong bourse on Thursday, April 23.

$HKG:3296$SHA:603296